logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate CAS 1235865-75-4

Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate CAS 1235865-75-4

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1235865-75-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
Appearance::
White To Off-white Powder
CAS NO::
1235865-75-4
Molecular Formula::
C15H11FN2O3
Molecular Weight::
286.25800
EINECS NO::
833-812-6
MDL NO::
MFCD28129691
Appearance::
White To Off-white Powder
CAS NO::
1235865-75-4
Molecular Formula::
C15H11FN2O3
Molecular Weight::
286.25800
EINECS NO::
833-812-6
MDL NO::
MFCD28129691
Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate CAS 1235865-75-4

Product Description:

Product Name: Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate CAS NO: 1235865-75-4


Synonyms:

methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate;

ABT199 intermediate 3;ABT199 intermediates;

ABT-199 Intermediate;


Chemical & Physical Properties:

Appearance: White to off-white powder

Assay :≥99.00%

Density: 1.377±0.06 g/cm3(Predicted)

Pka: 13.21±0.40(Predicted)

Boiling Point:444.0±45.0℃ at 760 mmHg

Flash Point: 222.3±28.7℃

Vapor Pressure: 0.0±1.1 mmHg at 25℃

Index of Refraction: 1.640


Safety Information:

Signal Word: Warning     

Precautionary Statements: P261-P305+P351+P338

Hazard Statements: H302-H315-H319-H335


Methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-fluorobenzoate is an intermediate of ABT 199, a potent and selective Bcl-2 inhibitor with strong antitumor activity while preserving platelets. Its practical use is in the treatment of chronic lymphocytic leukemia cells and e-strogen receptor positive breast cancer.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.